Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:25 pm Purchase | 2023-12-31 | 13G | iSun, Inc. ISUN | Anson Funds Management LP | 175,000 9.300% | 175,000 (New Position) | Filing History |
| 2024-02-14 4:25 pm Purchase | 2023-12-31 | 13G | Spero Therapeutics, Inc. SPRO | Anson Funds Management LP | 4,297,599 8.100% | 4,297,599 (New Position) | Filing History |
| 2024-02-14 4:17 pm Purchase | 2023-12-31 | 13G | XTI Aerospace, Inc. XTIA | Anson Funds Management LP | 774 9.900% | 774 (New Position) | Filing History |
| 2024-02-14 4:15 pm Sale | 2023-12-31 | 13G | Trilogy International Partners Inc. TRL | Anson Funds Management LP | 8,980,250 10.100% | -473,000 (-5.00%) | Filing History |
| 2024-02-14 4:15 pm Sale | 2023-12-31 | 13G | Nova LifeStyle, Inc. NVFY | Anson Funds Management LP | 74,300 4.400% | -1 (-0.00%) | Filing History |
| 2024-02-14 4:12 pm Purchase | 2023-12-31 | 13G | ZyVersa Therapeutics, Inc. ZVSA | Anson Funds Management LP | 16,067 9.800% | 16,067 (New Position) | Filing History |
| 2024-02-14 4:11 pm Purchase | 2023-12-31 | 13G | Greenwave Technology Solutions, Inc. MSRT | Anson Funds Management LP | 1,249,200 7.500% | 1,249,200 (New Position) | Filing History |
| 2024-02-14 4:10 pm Purchase | 2023-12-31 | 13G | 22nd Century Group, Inc. XXII | Anson Funds Management LP | 4 7.300% | 4 (New Position) | Filing History |
| 2024-02-14 4:06 pm Purchase | 2023-12-31 | 13G | BIOLASE, Inc. BIOL | Anson Funds Management LP | 185,127 8.100% | 185,127 (New Position) | Filing |
| 2024-02-07 5:51 pm Purchase | 2024-02-05 | 13D | VIEW INC VIEWQ | Anson Funds Management LP | 441,703 9.900% | 354,419 (+406.05%) | Filing History |
| 2023-11-03 5:30 pm Purchase | 2023-11-01 | 13D | Nano Dimension Ltd. NNDM | Anson Funds Management LP | 20,391,213 8.700% | 2,465,150 (+13.75%) | Filing History |
| 2023-11-01 5:20 pm Unchanged | 2023-10-31 | 13D | MEI Pharma, Inc. MEIP | Anson Funds Management LP | 1,093,188 16.400% | 0 (Unchanged) | Filing History |
| 2023-10-26 4:37 pm Purchase | 2023-10-16 | 13D | VIEW INC VIEWQ | Anson Funds Management LP | 87,284 2.200% | 87,284 (New Position) | Filing History |
| 2023-10-24 5:40 pm Purchase | 2023-10-20 | 13D | Nano Dimension Ltd. NNDM | Anson Funds Management LP | 17,926,063 7.600% | 2,326,200 (+14.91%) | Filing History |
| 2023-10-24 5:00 pm Purchase | 2023-10-20 | 13D | MEI Pharma, Inc. MEIP | Anson Funds Management LP | 1,093,188 16.400% | 179,000 (+19.58%) | Filing History |
| 2023-10-13 5:00 pm Purchase | 2023-10-11 | 13D | MEI Pharma, Inc. MEIP | Anson Funds Management LP | 914,188 13.700% | 50,000 (+5.79%) | Filing History |
| 2023-09-26 5:19 pm Purchase | 2023-09-22 | 13D | MEI Pharma, Inc. MEIP | Anson Funds Management LP | 864,188 13.000% | 48,060 (+5.89%) | Filing History |
| 2023-09-22 5:21 pm Purchase | 2023-09-20 | 13D | MEI Pharma, Inc. MEIP | Anson Funds Management LP | 816,128 12.200% | 153,600 (+23.18%) | Filing History |
| 2023-09-15 5:29 pm Unchanged | 2023-09-13 | 13D | MEI Pharma, Inc. MEIP | Anson Funds Management LP | 662,528 9.900% | 0 (Unchanged) | Filing History |
| 2023-08-08 4:41 pm Unchanged | 2023-08-04 | 13D | MEI Pharma, Inc. MEIP | Anson Funds Management LP | 662,528 9.900% | 0 (Unchanged) | Filing History |